Table 2 Changes in endothelial dysfunction and inflammation markers in all subjects (n=24). Data are means (±Standard error of mean).
| Markers |
baseline |
100 km |
200 km |
308 km |
| sVCAM-1 (ng·mL-1) |
870.51 (37.08) |
1233.17 (78.11) * |
921.80 (46.26) † |
953.65 (41.96) *† |
| sE-Selectin (ng·mL-1) |
30.21 (2.09) |
40.14 (2.75) * |
44.55 (2.94) * |
48.08 (4.04) *† |
| TNF-α (pg·mL-1) |
3.68 (.15) |
4.00 (.20) |
3.37 (.18) † |
4.50 (.36) *‡ |
| CK (U·L-1) |
113.92 (8.65) |
1311.35 (246.02) * |
8528.82 (1409.54) *† |
9368.97 (1652.07) *† |
| hs-CRP (mg·L-1) |
.40 (.10) |
5.06 (1.46) * |
25.56 (3.82) *† |
21.87 (3.49) *† |
| Leukocyte (x106/µL) |
6.20 (.32) |
13.10 (.61) * |
13.10 (.53) * |
12.86 (.93) *‡ |
| Hb (gm/dL) |
14.28 (.28) |
14.76 (.27) * |
13.91 (.26) † |
13.15 (.24) *† ‡ |
| Hct (%) |
41.89 (.75) |
42.87 (.66) |
40.24 (.68) *† |
38.49 (.65) *† ‡ |
